These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 1835341

  • 1. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
    Oda T, Konno T, Ohtsuka N, Kimura M, Mizumachi R.
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M, Konno T, Ohtsuka N, Mizumachi R, Oda T.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S, Fujihara A, Yamamoto M, Ida H, Ohmi Y, Kitazaki T, Kikuchi Y, Yoshida S, Okamiya H, Numasaki Y, Konno T.
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [Abstract] [Full Text] [Related]

  • 4. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S, Fujihara A, Yamamoto M, Asano M, Ida H, Ohmi Y, Kitazaki T, Kikuchi Y, Yoshida S, Okamiya H.
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [Abstract] [Full Text] [Related]

  • 5. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T, Maeda H.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [Abstract] [Full Text] [Related]

  • 6. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K, Konno T, Miyauchi Y, Maeda H.
    Cancer Res; 1987 Feb 01; 47(3):852-5. PubMed ID: 3026619
    [Abstract] [Full Text] [Related]

  • 7. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H.
    Gan To Kagaku Ryoho; 1989 Oct 01; 16(10):3323-31. PubMed ID: 2552930
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y, Takahashi K, Masuda E, Nohara C, Maeda H.
    Gan To Kagaku Ryoho; 1991 Oct 01; 18(13):2289-94. PubMed ID: 1834021
    [Abstract] [Full Text] [Related]

  • 9. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K, Saitoh S, Kumada H.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25 Suppl 1():19-23. PubMed ID: 9512682
    [Abstract] [Full Text] [Related]

  • 10. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S, Otsuki M.
    Curr Med Chem Anticancer Agents; 2002 Nov 01; 2(6):715-26. PubMed ID: 12678722
    [Abstract] [Full Text] [Related]

  • 11. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug 01; 18(10):1657-63. PubMed ID: 1651686
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A, Konno T, Kawaguchi T, Miyauchi Y, Maeda H.
    Cancer Res; 1992 Feb 15; 52(4):1013-7. PubMed ID: 1531320
    [Abstract] [Full Text] [Related]

  • 13. [SMANCS/lipiodol].
    Maeda H.
    Gan To Kagaku Ryoho; 1994 May 15; 21(6):907-13. PubMed ID: 8185354
    [Abstract] [Full Text] [Related]

  • 14. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
    Iwai K, Maeda H, Konno T.
    Cancer Res; 1984 May 15; 44(5):2115-21. PubMed ID: 6324996
    [Abstract] [Full Text] [Related]

  • 15. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension].
    Toge T, Jinushi K, Sawamura A, Matsuki K.
    Gan To Kagaku Ryoho; 1991 Aug 15; 18(10):1677-80. PubMed ID: 1651687
    [Abstract] [Full Text] [Related]

  • 16. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881].
    Saito T, Nakao I, Wakui A, Niitani H, Kurihara M, Konno T, Tsukagoshi S, Maeda H.
    Gan To Kagaku Ryoho; 1991 Jul 15; 18(8):1319-23. PubMed ID: 1829883
    [Abstract] [Full Text] [Related]

  • 17. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T.
    Gan To Kagaku Ryoho; 1987 Feb 15; 14(2):373-80. PubMed ID: 3028275
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F.
    Anticancer Res; 1992 Feb 15; 12(6B):2219-24. PubMed ID: 1295469
    [Abstract] [Full Text] [Related]

  • 19. [Intra-arterial injection of an oily antineoplastic agent in hepatic cancer].
    Konno T, Tashiro S, Maeda H, Iwai K, Ogata K, Mochinaga M, Uemura K, Ishimaru S, Miyauchi Y, Yokoyama I.
    Gan To Kagaku Ryoho; 1983 Feb 15; 10(2 Pt 2):351-7. PubMed ID: 6309086
    [Abstract] [Full Text] [Related]

  • 20. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K, Obuchi M, Honda M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1997 Nov 15; 24(14):2117-22. PubMed ID: 9388522
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.